Stephen Gerard Donnelly
Finanzdirektor/CFO bei KalVista Pharmaceuticals Ltd.
Ursprung des Netzwerks ersten Grades von Stephen Gerard Donnelly
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
KalVista Pharmaceuticals Ltd.
 KalVista Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology KalVista Pharmaceuticals Ltd. develops novel plasma kallikrein inhibitors. It also engages in the development of serine protease inhibitors and novel plasma kallikrein inhibitors represent a, approach to the treatment of DME, a leading cause of adult visual loss, plasma kallikrein inhibitors target a distinct molecular pathway and as such have the potential to offer those patients an effective treatment option. The firm has a clinical and advanced pre-clinical product pipeline targeting both intravitreal injection and oral administration, and its plasma kallikrein inhibitors can be applied to additional indications in ophthalmology. The company was founded by Lloyd Paul Aiello, Andrew Crockett, Robert Haigh and Edward P. Feener in 2011 and is headquartered in Porton Down, the United Kingdom.
10
| Subsidiary | Pharmaceuticals: Major | 10 |
Vantia Ltd.
 Vantia Ltd. Miscellaneous Commercial ServicesCommercial Services Vantia Ltd. services to provide molecule agonists of vasopressin receptors. It offers healthcare improve clinical treatments through development and commercialization of innovative medicines. The company was founded by Robert Haigh and Chris Yea in 2008 and is headquartered in Southampton, the United Kingdom.
2
| Holding Company | Miscellaneous Commercial Services | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Stephen Gerard Donnelly
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| ORACLE CORPORATION | Packaged Software | Corporate Officer/Principal | |
| AKSYS LTD. | Financial Conglomerates | Director/Board Member | |
FemRx, Inc.
 FemRx, Inc. Medical SpecialtiesHealth Technology Part of Johnson & Johnson, FemRx, Inc. is a company that produces medical products for gynecological disorders. The company is based in Sunnyvale, CA. FemRx was acquired by Johnson & Johnson on November 06, 1998 for $20.99 million. | Medical Specialties | Director of Finance/CFO | |
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Investment Managers | Private Equity Investor | |
VNUS Medical Technologies, Inc.
 VNUS Medical Technologies, Inc. Medical SpecialtiesHealth Technology VNUS Medical Technologies, Inc. provides medical devices and procedures for the minimally invasive treatment of venous reflux disease, an underlying cause of varicose veins. Venous reflux disease results in symptoms such as leg pain, swelling, fatigue, skin ulcers, and painful varicose veins. The company was founded on January 31, 1995 and is headquartered in San Jose, CA. | Medical Specialties | Director/Board Member | |
TRIA Beauty, Inc.
 TRIA Beauty, Inc. Medical SpecialtiesHealth Technology TRIA Beauty, Inc. provides light based therapeutic beauty devices. It offers TRIA Laser Hair Removal System for laser removal of hair and TRIA Skin Perfecting Blue Light for mild to moderate inflammatory acne with a proprietary cleanser and serum for overall complexion improvement. The company was founded in 2003 by Tobin C. Island, Robert E. Grove, Jonathon T. Pearson and Mark V. Weckwerth and is headquartered in Dublin, CA. | Medical Specialties | Director/Board Member Director/Board Member | |
Ceptaris Therapeutics, Inc.
 Ceptaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ceptaris Therapeutics, Inc. develops mechlorethamine gels. The firm develops a gel formulation of mechlorethamine hydrochloride for the treatment of early stage (stages I-IIA) mycosis fungoides, a type of Cutaneous T-Cell Lymphoma. The company was founded in 2002 and is headquartered in Malvern, PA. | Pharmaceuticals: Major | Director/Board Member | |
| REATA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
NextWave Pharmaceuticals, Inc.
 NextWave Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NextWave Pharmaceuticals, Inc. operates as a pharmaceutical company which focuses on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder. The company was founded by Mahendra G. Shah on September 25, 2006 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
AlterG, Inc.
 AlterG, Inc. Medical/Nursing ServicesHealth Services AlterG, Inc. develops weight reduction athletic equipment. Its products are used by major medical centers, leading physical therapy clinics and professional, collegiate, and individual sports and fitness programs. The firm?s products include anti gravity treadmill, bionic leg and accessories. AlterG was founded by Michael Brenton Looney, Fritz Moore, Edward Liou and Sean Whalen in 2005 and is headquartered in Fremont, CA. | Medical/Nursing Services | Director/Board Member | |
| MINERVA SURGICAL, INC. | Medical Specialties | Director/Board Member | |
Vicept Therapeutics, Inc.
 Vicept Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vicept Therapeutics Inc. develops dermatologic therapeutic products. The firm develops topical agents for the treatment and prevention of a number of medical and cosmetic indications including bruising of the skin. The company was founded on July 1, 2009 by Neal Walker, Stewart D. Shanler, and Christopher V. Powala and is headquartered in Malvern, PA. | Pharmaceuticals: Major | Director/Board Member | |
| ACLARIS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Stanford University | College/University | Undergraduate Degree Masters Business Admin | |
| The University of Manchester | College/University | Doctorate Degree Doctorate Degree | |
| Scandinavian International Management Institute | College/University | Corporate Officer/Principal | |
Neomend, Inc.
 Neomend, Inc. BiotechnologyHealth Technology Neomend, Inc. develops surgical wound healing products. It offers adhesion prevention products for hospitals and medical facilities. The company was founded in 1999 and is headquartered in Irvine, CA. | Biotechnology | Director/Board Member | |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Ferring Research Institute, Inc.
 Ferring Research Institute, Inc. Drugstore ChainsRetail Trade Ferring Research Institute, Inc. is a biopharmaceutical company, which engages in identifying, developing, and marketing of products. It focuses on the fields of endocrinology, gastroenterology, infertility, obstetrics, urology and osteoarthritis. The company is headquartered in San Diego, CA. | Drugstore Chains | Chief Tech/Sci/R&D Officer | |
| ASCENDIS PHARMA A/S | Pharmaceuticals: Major | Chairman | |
The Bioindustry Association
 The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Director/Board Member | |
| Praxon, Inc. | Director of Finance/CFO | ||
| David Geffen School of Medicine | College/University | Doctorate Degree | |
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Pharmaceuticals: Major | Director/Board Member | |
Morphic Therapeutic, Inc.
 Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Biotechnology | Director/Board Member | |
| MORPHIC HOLDING, INC. | Pharmaceuticals: Major | Director/Board Member | |
| KALVISTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Chairman Director/Board Member Director/Board Member Director/Board Member Chairman Founder Founder Corporate Officer/Principal Founder | |
Novo Holdings A/S (Investment Company)
 Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings A/S (Investment Company) (Novo Holdings-IC) is the investment portfolio division of Novo Holdings A/S, a holding company headquartered in Hellerup, Denmark. They are ultimately owned by Novo Nordisk Fonden (Novo Nordisk Foundation). Founded in 1999, Novo Holdings-IC manages a broad portfolio of the Foundation’s financial assets. | Financial Conglomerates | Corporate Officer/Principal | |
| HARMONY BIOSCIENCES HOLDINGS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Dermatology Innovation Forum | Founder | ||
Frazier Life Sciences Management LP
 Frazier Life Sciences Management LP Investment ManagersFinance Frazier Life Sciences Management LP (Frazier Life Sciences) is a private investment manager headquartered in Menlo Park, California. The firm was founded in 2021 as a newly spun off company from Frazier Management LLC. They are principally owned by Jamie Topper and Patrick Heron. Frazier Life Sciences provides discretionary investment management services to US private investment funds, Frazier Life Sciences Funds. | Investment Managers | Corporate Officer/Principal |
Statistik
International
| Vereinigte Staaten | 43 |
| Dänemark | 4 |
| Vereinigtes Königreich | 4 |
| Kanada | 2 |
| Israel | 2 |
Sektoral
| Health Technology | 35 |
| Finance | 5 |
| Consumer Services | 5 |
| Health Services | 3 |
| Commercial Services | 3 |
Operativ
| Director/Board Member | 119 |
| Independent Dir/Board Member | 28 |
| Founder | 23 |
| Corporate Officer/Principal | 23 |
| Chairman | 20 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Martin Edwards | 38 |
| Arnold Lewis Oronsky | 35 |
| Richard H. Aldrich | 31 |
| Albert Cha | 30 |
| Brian Pereira | 23 |
| Edward Unkart | 13 |
| Robert Haigh | 7 |
| T. Crockett | 7 |
| Ed Feener | 4 |
| Christopher Yea | 4 |
| Lloyd Paul Aiello | 2 |
- Börse
- Insiders
- Stephen Gerard Donnelly
- Unternehmensverbindungen